GlassScriptPhysician profile
George J Bitar
NPI 1306976709
$30,809.48
in general payments reported to CMS, 2019-2025
13 companies · $312 in 2025
The $312 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $682 · 2021: $534 · 2022: $529 · 2023: $4,529 · 2024: $3,927 · 2025: $312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,097 · Consulting Fee: $2,250 · Travel and Lodging: $2,086 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,097.20 |
| Consulting Fee | $2,250.00 |
| Travel and Lodging | $2,086.28 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,335.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $24,386.68 | 2019-2024 | Xeomin |
| Allergan, INC. | $2,371.46 | 2019-2022 | |
| Abbvie INC. | $1,464.23 | 2024-2025 | |
| Galderma Laboratories, L.P. | $517.55 | 2019-2025 | Dysport |
| Integra Lifesciences Corporation | $475.44 | 2022-2023 | Durasorb Monofilament Mesh, Tenoglide |
| Smith+Nephew, INC. | $433.33 | 2019-2023 | Grafix |
| Baxter Healthcare | $272.13 | 2024-2025 | Artiss |
| Mentor Worldwide LLC | $249.74 | 2019-2021 | |
| Bard Peripheral Vascular, INC. | $217.74 | 2021 | |
| Coopersurgical, INC. | $134.43 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $124.64 | 2019 | |
| Avita Medical Americas, LLC | $118.10 | 2024 | |
| Sanara Medtech INC. | $44.01 | 2024 | Celleraterx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Bitar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.